Pharmacokinetic/Pharmacodynamic Modelling of Antibacterials In Vitro and In Vivo Using Bacterial Growth and Kill Kinetics: The Minimum Inhibitory Concentration versus Stationary Concentration

By Johan W. Mouton  

Clinical Pharmacokinetics, Vol. 44, Iss. 2, 2005-01 ,pp. : 201-210

Adis International

Access to resources Recommend Favorite

3-Alkylthiomethyl-1-ethylimidazolium chlorides. Correlation between critical micelle concentrations and minimum inhibitory concentrations

By Pernak J.   Skrzypczak A.  

European Journal of Medicinal Chemistry, Vol. 31, Iss. 11, 1996-01 ,pp. : 901-903

Elsevier

Access to resources Recommend Favorite

Clinical Use of Ceftriaxone: A Pharmacokinetic-Pharmacodynamic Perspective on the Impact of Minimum Inhibitory Concentration and Serum Protein Binding

By Perry T.R.   Schentag J.J.  

Clinical Pharmacokinetics, Vol. 40, Iss. 9, 2001-01 ,pp. : 685-694

Adis International

Access to resources Recommend Favorite

Relationship Between Carbapenems Structure and Minimal Inhibitory Concentration Selected Bacterial Strains

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 5, 2016-06 ,pp. : 422-428

Bentham Science Publishers

Access to resources Recommend Favorite

Integration of pharmacokinetic/pharmacodynamic modeling and simulation in the development of new anti-infective agents – minimum inhibitory concentration versus time-kill curves

By Schmidt Stephan   Schuck Edgar   Kumar Vipul   Burkhardt Olaf   Derendorf Hartmut  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 849-860

Informa Healthcare

Access to resources Recommend Favorite